申请人:CELGENE QUANTICEL RESEARCH, INC.
公开号:US10273222B2
公开(公告)日:2019-04-30
The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted imidazole-pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase enzymes. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本发明提供了取代的咪唑吡啶衍生物化合物和包含所述化合物的药物组合物。所述化合物和组合物可用于抑制组蛋白去甲基化酶。此外,所述化合物和组合物还可用于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。